| BIAsp 30 (biphasic insulin aspart 30/70 biosimilar) / Novo Nordisk |
NCT01467323: Efficacy and Safety of Biphasic Insulin Aspart 30 in Type 1 or Type 2 Diabetes |
|
|
| Completed | 3 | 303 | Europe | biphasic insulin aspart, biphasic human insulin | Novo Nordisk A/S | Diabetes, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2 | 09/98 | 09/98 | | |
NCT01486381: Long Term Safety of Biphasic Insulin Aspart 30 in Juveniles With Type 1 Diabetes |
|
|
| Completed | 3 | 22 | RoW | biphasic insulin aspart 30 | Novo Nordisk A/S | Diabetes, Diabetes Mellitus, Type 1 | 05/03 | 05/03 | | |
NCT00617565: Efficacy and Safety of Biphasic Insulin Aspart 30 in Type 1 or 2 Diabetes |
|
|
| Completed | 3 | 219 | RoW | biphasic insulin aspart, BIASP, biphasic human insulin | Novo Nordisk A/S | Diabetes, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2 | 11/03 | 11/03 | | |
| Completed | 3 | 242 | US | biphasic insulin aspart, insulin glargine, metformin, pioglitazone | Novo Nordisk A/S | Diabetes, Diabetes Mellitus, Type 2 | 03/04 | 03/04 | | |
NCT00280046: Effect of Biphasic Insulin Aspart 30 on Blood Glucose Control in Subjects With Type 2 Diabetes |
|
|
| Completed | 3 | 307 | RoW | biphasic insulin aspart | Novo Nordisk A/S | Diabetes, Diabetes Mellitus, Type 2 | 07/04 | 07/04 | | |
NCT01527539: Long Term Safety and Efficacy of Biphasic Insulin Aspart 30 in Subjects With Type 2 Diabetes |
|
|
| Completed | 3 | 25 | Canada | biphasic insulin aspart 30 | Novo Nordisk A/S | Diabetes, Diabetes Mellitus, Type 2 | 10/04 | 10/04 | | |
NCT01467375: Long Term Safety and Efficacy of Biphasic Insulin Aspart 30 in Type 2 Diabetes |
|
|
| Completed | 3 | 89 | Canada, RoW | biphasic insulin aspart | Novo Nordisk A/S | Diabetes, Diabetes Mellitus, Type 2 | 10/04 | 10/04 | | |
PreFER, NCT00605020: Efficacy and Safety of Insulin Detemir in Combination With Insulin Aspart and Biphasic Insulin Aspart 30 in Type 2 Diabetes |
|
|
| Completed | 3 | 719 | Europe | insulin detemir, Levemir, insulin aspart, biphasic insulin aspart | Novo Nordisk A/S | Diabetes, Diabetes Mellitus, Type 2 | 03/05 | 03/05 | | |
NCT00184574: Comparison of Biphasic Insulin Aspart 70/30, 50/50, and 30/70 in Subjects With Type 2 Diabetes |
|
|
| Completed | 3 | 603 | Europe, RoW | biphasic insulin aspart, metformin | Novo Nordisk A/S | Diabetes, Diabetes Mellitus, Type 2 | 03/06 | 03/06 | | |
NCT00318786: Efficacy and Safety of Three Times a Day BIAsp-70 Compared to Two Times a Day BIAsp-30 in Subjects With Type 2 Diabetes |
|
|
| Completed | 3 | 289 | Japan | biphasic insulin aspart | Novo Nordisk A/S | Diabetes, Diabetes Mellitus, Type 2 | 06/07 | 06/07 | | |
NCT00627445: Effect of Biphasic Insulin Aspart 50 on Blood Glucose Control in Subjects With Type 2 Diabetes |
|
|
| Completed | 3 | 441 | RoW | biphasic insulin aspart 30, metformin, biphasic insulin aspart 50 | Novo Nordisk A/S | Diabetes, Diabetes Mellitus, Type 2 | 01/09 | 01/09 | | |
| Completed | 3 | 708 | Europe | biphasic insulin aspart, insulin detemir, insulin aspart | Novo Nordisk A/S | Diabetes, Diabetes Mellitus, Type 2 | 08/09 | 08/09 | | |
| Completed | 3 | 447 | Europe, RoW | insulin degludec/insulin aspart, biphasic insulin aspart 30 | Novo Nordisk A/S | Diabetes, Diabetes Mellitus, Type 2 | 08/10 | 08/10 | | |
|
|
|
BOOSTâ„¢, NCT01059812: A Pan Asian Trial Comparing Efficacy and Safety of NN5401 and Biphasic Insulin Aspart 30 in Type 2 Diabetes |
|
|
| Completed | 3 | 424 | Japan, RoW | insulin degludec/insulin aspart, biphasic insulin aspart 30 | Novo Nordisk A/S | Diabetes, Diabetes Mellitus, Type 2 | 12/10 | 12/10 | | |
|
NCT00151697: LANN-study: Lantus, Amaryl, Novorapid, Novomix Study |
|
|
| Completed | 3 | 150 | Europe | Novomix 30, Novorapid and Amaryl, Lantus | Rijnstate Hospital | Diabetes Mellitus Type II | | | | |
NCT01513590 / 2011-001712-61: A Trial Comparing Efficacy and Safety of Insulin Degludec/Insulin Aspart and BIAsp 30 in Insulin naïve Subjects With Type 2 Diabetes |
|
|
| Completed | 3 | 394 | Europe, RoW | insulin degludec/insulin aspart | Novo Nordisk A/S | Diabetes, Diabetes Mellitus, Type 2 | 11/12 | 11/12 | | |
BOOST, NCT02762578: Comparing Efficacy and Safety of Insulin Degludec/Insulin Aspart and BIAsp 30 in Subjects With Type 2 Diabetes |
|
|
| Completed | 3 | 543 | RoW | insulin degludec/insulin aspart, biphasic insulin aspart | Novo Nordisk A/S | Diabetes, Diabetes Mellitus, Type 2 | 05/17 | 06/17 | | |
